Relay Medical Appoints Moshe Katzenelson as Senior Vice President, Global Business Development
(firmenpresse) - June 26, 2019 - Relay Medical Corp. (Relay or the Company) (CSE: RELA, OTC: RYMDF, Frankfurt: EIY2), an engine of MedTech innovation, is pleased to announce the appointment of Moshe Katzenelson as Senior Vice President, Global Business Development.
For over 25 years Mr. Katzenelson has played a pivotal role in the advancement of high-tech innovation in Israels burgeoning technology industry and bringing that innovation to international markets through business development leadership. As Senior Vice President of Global Business Development, Moshe will lead Relays business development team in the global expansion of Relay assets and the search for new technologies to be developed into innovative product offerings. Moshe will also be responsible for selling the rights to such products to global MedTech players.
Moshes track record of leadership, successful business development and international expansion, will be highly beneficial to the advancement of Relays technologies and group of companies, as demonstrated by his leadership at the Incubator of the Technion Institute in Israel and in his most recent role, where he built the Trendlines accelerator in Singapore. said Lahav Gil, CEO, Relay Medical Corp. Moshe brings to Relay unprecedented access to Tel Avivs technology and innovation ecosystem, as well as access to the venture financing community in Israel and strategic MedTech companies in Europe. He is also connected to the Israeli networks for agriculture and cannabis related technology innovation and commercialization hubs which will be valuable to our Glow Lifetech venture with Agraflora Organics. We are very excited and pleased to welcome Moshe into the Relay Medical family.
Relays capabilities and business model are unique and exciting, and I look forward to working with Relays excellent team on making a mark on the MedTech industry. said Moshe Katzenelson, SVP Global Business Development
Over the span of his career as an international medtech executive Mr. Katzenelson has led, invested in and actively nurtured start-up companies, much of that time as CEO of LabOne Ventures and Technion Seed - two early-stage investment firms in Israel. An engineer by background, and holding an MBA from the Tel-Aviv university, Moshe also gained much experience in project management and global business development, having successfully led such work for several leading companies, most recent of which were Netafim (a pioneer and global leader in irrigation solutions) and the Trendlines Group - one of Israels most prestigious seed investment firms - where he was responsible for the firms international expansion, and most notably the establishing of an incubator for investing in and nurturing medical device ventures in Singapore. Moshe operates from Israel, where he strengthens Relays global reach to innovators and leading MedTech companies in Europe and Asia.
About Relay Medical Corp.
Relay Medical is an evolving Integrated MedTech Accelerator headquartered in Toronto, Canada, acquiring early-stage technologies and inventions, advancing and preparing them for pre-commercial acquisitions in the HealthTech marketplace. By integrating the funding, development and exit process into one organization led and managed by one expert team, Relay Medical is building the capacity to accelerate and transact technologies with high efficiency and grow into a leading engine for MedTech innovation in the global HealthTech marketplace.
Website: www.relaymedical.com
Contact:
W. Clark Kent
President
Relay Medical Corp.
Office. 647-872-9982 ext. 2
TF. 1-844-247-6633 ext. 2
investor.relations(at)relaymedical.com
Bernhard Langer
EU Investor Relations
Office. +49 (0) 177 774 2314
Email: blanger(at)relaymedical.com
Contact:
Office: 647-872-9982
Toll-free/Fax: 1-844-247-6633
Email: info(at)relaymedical.com
Suite 1600-401 Bay St.
Toronto, Ontario M5H 2Y4
Forward-looking Information Cautionary Statement
Except for statements of historic fact, this news release contains certain "forward-looking information" within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements are based on the opinions and estimates at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements including, but not limited to delays or uncertainties with regulatory approvals, including that of the CSE. There are uncertainties inherent in forward-looking information, including factors beyond the Companys control. There are no assurances that the commercialization plans for the HemoPalm product described in this news release will come into effect on the terms or time frame described herein. The Company undertakes no obligation to update forward-looking information if circumstances or management''s estimates or opinions should change except as required by law. The reader is cautioned not to place undue reliance on forward-looking statements. Additional information identifying risks and uncertainties that could affect financial results is contained in the Companys filings with Canadian securities regulators, which filings are available at www.sedar.com
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
" alt="Caledonia Mining Corporation Plc: Notification of relevant change to significant shareholder">
" alt="American Manganese Produces High Purity Material from Pilot Plant Project">
Datum: 27.06.2019 - 01:26 Uhr
Sprache: Deutsch
News-ID 1550261
Anzahl Zeichen: 4985
contact information:
Contact person:
Town:
Wien
Phone:
Kategorie:
Business News
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 578 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Relay Medical Appoints Moshe Katzenelson as Senior Vice President, Global Business Development
"
steht unter der journalistisch-redaktionellen Verantwortung von
Relay Medical Corp. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
